Domestic technology for placenta injectable near commercialized.

Published: 2004-10-29 06:56:00

Updated: 2004-10-29 06:56:00

It is near ready for the human placenta to be commercially available in Korea after due technology success in isolating and purifying the bio active substances from crude human placenta.

Bio R&Ds (President: Choi Moon-soo) took a signing ceremony of the technology licensing agreement with Dongdeok Pharm. Co. (President: Kim Seon-koo) at the grand ballroom of Coex building on Oct. 15 for the ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.